Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2012/02/22
-
Journal
-
Indian UGC (journal)
-
Refrences32
-
Citations92
-
M.D. Piroth
-
M. Pinkawa
-
R. Holy
-
J. Klotz
-
S. Schaar
-
G. Stoffels
-
N. Galldiks
-
H.H. Coenen
-
H.J. Kaiser
-
K.J. Langen
-
M.J. Eble
Cite
Piroth, M.D., et al. “Integrated Boost IMRT With FET-PET-Adapted Local Dose Escalation in Glioblastomas”. Strahlentherapie Und Onkologie, vol. 188, no. 4, 2012, pp. 334-9, https://doi.org/10.1007/s00066-011-0060-5.
Piroth, M., Pinkawa, M., Holy, R., Klotz, J., Schaar, S., Stoffels, G., Galldiks, N., Coenen, H., Kaiser, H., Langen, K., & Eble, M. (2012). Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Strahlentherapie Und Onkologie, 188(4), 334-339. https://doi.org/10.1007/s00066-011-0060-5
Piroth M, Pinkawa M, Holy R, Klotz J, Schaar S, Stoffels G, et al. Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Strahlentherapie und Onkologie. 2012;188(4):334-9.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Medicine (General)
Medicine
Medicine (General)
Medical physics
Medical radiology
Nuclear medicine
You May Also Like
- Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
- Thermal dose determination in cancer therapy
- Use of Normal Tissue Complication Probability Models in the Clinic
- Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
- Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Prolonged survival when temozolomide is added to accelerated radiotherapy for glioblastoma multiforme | Strahlentherapie und Onkologie |
| 16 | 2011 |
| Radiochemotherapy with temozolomide for patients with glioblastoma | Strahlentherapie und Onkologie |
| 15 | 2011 |
| Prognostic impact of postoperative, pre-irradiation 18F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy | Radiotherapy and Oncology |
| 61 | 2011 |
| Prognostic Value of Early [18F]Fluoroethyltyrosine Positron Emission Tomography After Radiochemotherapy in Glioblastoma Multiforme | International Journal of Radiation Oncology*Biology*Physics |
| 96 | 2011 |
| 18F-FET-PET-Based Dose Painting by Numbers with Protons | Strahlentherapie und Onkologie |
| 11 | 2010 |
Refrences Analysis
The category
Medicine: Medicine (General) 8
is the most frequently represented among the references in this article. It primarily includes studies from Journal of Neurosurgery The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| PRIDE: isotoxic dose escalation in glioblastoma | Forum | 2024 | ||
| Dosimetric feasibility analysis and presentation of an isotoxic dose-escalated radiation therapy concept for glioblastoma used in the PRIDE trial (NOA-28; ARO-2022-12) | Clinical and Translational Radiation Oncology | 2024 | ||
Integrating multi-modal imaging in radiation treatments for glioblastoma | Neuro-Oncology |
| 2024 | |
Evolving concepts in margin strategies and adaptive radiotherapy for glioblastoma: A new future is on the horizon | Neuro-Oncology |
| 2024 | |
Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma | Journal of Medical Signals & Sensors |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 52
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Contribution of 18F-Fluoro-ethyl-tyrosine Positron Emission Tomography to Target Volume Delineation in Stereotactic Radiotherapy of Malignant Cranial Base Tumours: First Clinical Experience and was published in 2012. The most recent citation comes from a 2024 study titled Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma. This article reached its peak citation in 2013, with 15 citations. It has been cited in 56 different journals, 23% of which are open access. Among related journals, the Neuro-Oncology cited this research the most, with 7 citations. The chart below illustrates the annual citation trends for this article.